CARVEDILOL
Cardiometabolic Risk Factors
Post Graduate Institute of Medical Education and Research, ChandigarhSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
2 Active assets in the Cardiometabolic Risk Factors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fermented grape flour Hospices Civils de Lyon | N/A | D |
Amg 513 Amgen | Phase 1 | NR |
Same molecule, other indications
CARVEDILOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →